Young oncologists in the coronavirus crisis: a learning opportunity
Despite some share the concern of having their career plans delayed or disrupted by the pandemic, the new challenges emerged in these unprecedented times represent a unique opportunity to grow-up as oncology professionals and get ready to a new scenario where team working, humanisation of care and virtual education will be more crucial than ever.
Telemedicine: the good and bad of living a hype
Why we need to investigate sex differences in cancer research
Sex- and gender-sensitive medicine postulates that differences in biological sex, gender identity, role and relations all impact health and disease, and may have implications for prevention, screening, diagnosis and treatment. Its goal is to learn from these differences to improve care and treatment for men and women.
Off-label therapies: what is their future?
Many studies presented at the Congress hint at promising treatments for rare sarcomas but access to effective treatments remains a challenge
Immunotherapy fails to improve PFS and OS in relapsed mesothelioma
Results from the PROMISE-meso trial presented
Sex and gender-sensitive medicine: are we ready to switch paradigm?
Examining sex- and gender-related differences may potentially be the new frontier in the era of precision medicine to tailor cancer treatments in men and women.